F. Brunet‐Possenti
- Dermatology top 10%
- Cutaneous lymphoproliferative disorders research 10
-
- Cancer Immunotherapy and Biomarkers 9
- Cutaneous Melanoma Detection and Management 9
- CAR-T cell therapy research 8
-
- Nonmelanoma Skin Cancer Studies 7
- Nail Diseases and Treatments 4
-
- Autoimmune Bullous Skin Diseases 4
-
- Melanoma and MAPK Pathways 6
- Co-authors
- V. DescampsLaurent MortierCaroline DutriauxN. DupinLydia DeschampsStéphane DalleHenri MontaudiéCélèste Lebbé
- Cited by
- DermatologyOncologyVirology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (5 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
F. Brunet‐Possenti
31 papers receiving 188 citations
Peers
Comparison fields: 5 of 40
- Dermatology 57
- Oncology 104
- Virology 12
- Epidemiology 85
- Pathology and Forensic Medicine 34
Countries citing papers authored by F. Brunet‐Possenti
This map shows the geographic impact of F. Brunet‐Possenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Brunet‐Possenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Brunet‐Possenti more than expected).
Fields of papers citing papers by F. Brunet‐Possenti
This network shows the impact of papers produced by F. Brunet‐Possenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Brunet‐Possenti. The network helps show where F. Brunet‐Possenti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Brunet‐Possenti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 2 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 6 | |
| 16 | 2016 | 3 | |
| 17 | 2016 | 0 | |
| 18 | 2013 | 6 | |
| 19 | 2012 | 6 | |
| 20 | 2011 | 7 |
About F. Brunet‐Possenti
F. Brunet‐Possenti is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine, having authored 37 papers that have together received 191 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cutaneous Melanoma Detection and Management (9 papers), CAR-T cell therapy research (8 papers), Nonmelanoma Skin Cancer Studies (7 papers), Melanoma and MAPK Pathways (6 papers), Nail Diseases and Treatments (4 papers) and Autoimmune Bullous Skin Diseases (4 papers). The work is most often cited by research in Dermatology (57 citations), Oncology (104 citations) and Virology (12 citations). F. Brunet‐Possenti has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include V. Descamps, Laurent Mortier, Caroline Dutriaux, N. Dupin, Lydia Deschamps, Stéphane Dalle, Henri Montaudié, Célèste Lebbé, Julie De Quatrebarbes and Caroline Robert. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.